News
The FDA has approved a new therapy to treat advanced melanoma, with some patients' cancer disappearing completely.
The discovery may explain why cutting edge CAR T-cell therapy has managed to revolutionized treatment for blood cancer but ...
1d
News-Medical.Net on MSNUCLA study may help explain why certain liver tumors return after thermal ablationA new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...
4don MSN
A collaborative research team has successfully developed a novel fluorescent probe, SLY (Sialyl Lewis Yellow), capable of ...
A new magnet array at Brookhaven Lab can steer cancer-killing proton beams at record energy levels up to 250 MeV. This magnet ...
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.
1d
News Medical on MSNHydrogels could be key to safer, smarter cancer drug deliveryHydrogels could revolutionize cancer treatment by facilitating targeted drug delivery, reducing adverse effects, and ...
Researchers have developed a wireless implantable drug delivery system that enables anticancer drugs to penetrate deep into ...
22h
Medpage Today on MSNBiomarker Testing in Advanced Cancer Still Lags Behind Guideline RecommendationsOverall, 35% of patients' records had evidence of comprehensive genomic profiling (CGP). The rate increased modestly from 32% at the beginning of the study period to 39% at the end, reported Stacey ...
Studies show in mice show that targeting the metabolic pathways could inhibit the growth of melanoma and combining this ...
We also found that tumors release a protein called Activin-A, which acts on blood vessels to cause the leakiness and, ultimately, loss of blood vessels in the muscle. When we used a gene therapy to ...
The American Brain Tumor Association (ABTA) combines fitness, music, and medical expertise for 2nd Annual Cleveland BT5K on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results